First Turn Management’s Praxis Precision Medicines PRAX Stock Holding History

First Turn Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.7M	Buy	42,441 +6,692	+19%	+$2.07M	1.53%	30
2025 Q4	$10.5M	Buy	+35,749	New	+$6.66M	1.2%	31
2025 Q2	–	Sell	-71,775	Closed	-$2.72M	–	41
2025 Q1	$2.72M	Buy	71,775 +26,239	+58%	+$1.64M	0.55%	34
2024 Q4	$3.5M	Buy	+45,536	New	+$3.29M	0.63%	36

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

First Turn Management's PRAX Position: Q1 2026 in Review

First Turn Management increased its Praxis Precision Medicines (PRAX) stake by 19% in Q1 2026, buying an estimated $2.07M and bringing the position to 42,441 shares worth $13.7M. The position accounts for 1.53% of the portfolio, ranked #30.

First Turn Management first reported a position in PRAX in Q4 2024 and has held it in 4 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

First Turn Management held 42,441 shares of Praxis Precision Medicines worth $13.7M as of Q1 2026.
First Turn Management bought 6,692 Praxis Precision Medicines shares in Q1 2026, an estimated $2.07M.
Praxis Precision Medicines made up 1.53% of First Turn Management's portfolio in Q1 2026, its #30 holding.
First Turn Management first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 4 quarters since.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on First Turn Management's 13F filing for Q1 2026, filed 15 May 2026.